OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

obeq
LdOdaySAalsnyl L
SAILIMGISNOdSAYSAALSNYLJOLNSAINSLVIS v
LYOd4yS.YOLIGNVLINSGQNSdSqNI S
SAILLIALLOVTVIONVNId40LNSWSALVLS Z
L35dHSSAONVIVa 8
SLNNOOOVSHLOLSALON 6

Unrestricted Endowment Total Unrestricted Endowment Total
Fund Fund Fund Fund Fund Fund
2024 2024 2024 2023 2023 2023
£ £ £ £ £ £
Incomefrom:
Investments 101,424 - 101,424 97,035 - 97,035
Expenditureon:
Charitableactivities 98,718 - 98,718 90,245 - 90,245
(Note3)
Netgains/(losses)
oninvestments(Note
4)
- 192,390 192,390 - (236,871) (236,871)
NetIncome/
(Expenditure) 2,706 192,390 195,096 6,790 (236,871) (230,081)
TotalFundsbrought
forwardat1April
2023 141,533 2,429,173 2,570,706 134,743 2,666,044 2,800,787
TotalFundscarried
forwardat31March
2024 144,239 2,621,563 2,765,802 141,533 2,429,173 2,570,706
Allamountsrelateto continuingoperations

2024 023
Note £ £ £ £
FIXEDASSETS
Investments 4 2,621,563 2,429,173
CURRENTASSETS
Accruedincome 5 6,655 5,870
BankBalances 275,589 306,150
282,244 312,020
CREDITORS:AMOUNTSFALLING
6
DUEWITHINONEYEAR (138,005) (170,487)
NETASSETS 2,765,802 2,570,706
Representing:
FUNDS
EndowmentFunds 2,9,10 2,621,563 2,429,173
UnrestrictedFunds 9,10 144,239 141,533
2,765,802 2,570,706

ANALYSISOFEXPENDITURE
Direct Support
Total
Total
costs costs
2024
2023
£ £ £ £
GrantstoNorthLondonCollegiateSchool
MusicScholarshipawards 46,000 -
46,000
45,000
AdvancementofEducationinScience
-ScienceEquipment - ~
-
10,510
-ScienceLaboraiories 33,000 -
33,000
33,000
Annual SciencePrize 225 ~
225
150
Othercharitable andeducationalpurposes
-SupplementarygrantstoBursary Holders 3,000 ~
3,000
4,000
-Choralandinstrumentalmasterclasses 10,500 -
10,500
2,250
-Extendedessaysandsciencedisplays 8,500 -
8,500
-
UnusedamountsreturnedtoTrust (6,287)
(6,287)
(8,265)
Governance
Auditfee - 3,780 3,780 3,600
Total 94,938 3,780 98,718 90,245
INVESTMENTS
InvestmentsoftheTrustcomprise: Market value
2024 2023
£ £
UKlistedequities-Glaxo 300,714 251,504
-Haleon 73,282 -
M&GEquitiesFundforCharities 815,405 830,575
BlackRockCharitiesEquitiesFund 101,239 98365
COIFCharitiesInvestmentFund 662,200 606,492
BlackRockGrowthandIncomeFund 294,367 287,886
COIFCharitiesFixedInterestFund 254,260 242,702
NewtonGrowthandIncomeFund 120,096 111,649
2,621,563 2,429,173
Movementsduringtheyearwere:
Market Market
Value2024 Value2023
£ £
Broughtforwardat7April2023 2,429,173 2,666,044
Unrealisedgains/(losses) 192,390 (236,871)
Carriedforwardat31March2024 2,621,563 2,429,173
Investmentmanagerfeesarerecoveredwithinpooledinvestment funds

ACCRUEDINCOME 2024 2023
£ £
GlaxoSmithKlineincome 2,800 2,420
NewtonGrowthandIncomeFund 500 400
BlackRock-InvestmentFunds 3,355 3,050
6,655 5,870
6 CREDITORS 2024 2023
£ £
NorthLondonCollegiateSchool 134,225 166,887
Othercreditors 3,780 3,600
138,005 170,487
TRUSTEES
NoneoftheTrusteesreceivedanyremuneration.
NETMOVEMENTINFUNDS
Netmovementinfundsfortheyearisstatedaftercharging thefollowing:
2024 2023
£ £
Amountspaidtoauditors
Auditservices—CroweU.K.LLP 3,780 3,600
3,780 3,600
ANALYSISOFNETASSETSBETWEENFUNDS
Fundbalancesat31March2024are representedby:
Total Total
Unrestricted Endowment Funds Funds
Funds Funds 2024 2023
£ £ £ £
FixedAssetsandInvestments - 2,621,563 2,621,563 2,429,173
CurrentAssets 282,244 - 282,244 312,020
Creditors
Amountsfallingduewithinoneyear (138,005) - (138,005) (170,487)
Carriedforwardat31March2024 144,239 2,621,563 2,765,802 2,570,706

At1April Unrealised At31March
2023 Income Expenditure gain 2024
£ £ £ £ £
EndowmentFunds 2,429,173 - - 192,390 2,621,563
UnrestrictedFunds 141,533 101,424 (98,718) - 144,239
Total 2,970,706 101,424 (98,718) 192,390 2,765,802
11 COMPARATIVENOTES-ANALYSISOFNETASSETS BETWEENFUNDS
Fundbalancesat31March 2023arerepresentedby:
Total Total
Unrestricted Endowment Funds Funds
Funds Funds 2023 2022
£ £ £ £
FixedAssetsandinvestments - 2,429,173 2,429,173 2,666044
CurrentAssets 312,020 - 312,020 217,444
Creditors
Amountsfallingduewithin oneyear (170,487)
-

(170,487)
(82,701)
Carriedforwardat31March 2023 141,533 2,429,173 2,570,706 2,800,787
COMPARATIVENOTES-STATEMENT OFFUNDS
At1April (Realisedloss) At31March
2022 Income Expenditure unrealisedgain 2023
£ £ £ £ £
EndowmentFunds 2,666,044 - - (236,871) 2,429,173
UnrestrictedFunds 134,743 97,035 (90,245) 141,533
Total 2,800,787 97,035 (90,245) (236,871) 2,570,706